Unveiling Blind Spots: How CH Prediction Can Transform Biomarker Strategies
Time: 8:30 am
day: Day One AM
Details:
- Unmask Critical Challenges in CH Prediction: Discover how blind spots in conventional diagnostic approaches to clonal hematopoiesis (CH) can lead to misinterpretation, missed signals, and trial delays
- Case Study Insights That Redefine Precision: Dive into a real-world case study showcasing how Foundation Medicine’s advanced tools predict and differentiate CH, delivering actionable insights that can strengthen trial design
- Accelerate Your Path to Market: See how addressing CH complexities can empower biopharma teams to optimize timelines, reduce risks, and advance therapies to patients with greater confidence
